These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6211532)

  • 1. Penetration of moxalactam into CSF.
    Landesman SH
    J Pediatr; 1982 Jul; 101(1):160-1. PubMed ID: 6211532
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
    Ramos OM; Kaplan SL; Mason EO; Denson S; Pickering LK
    South Med J; 1982 May; 75(5):632-3. PubMed ID: 6210970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxalactam penetration into cerebrospinal fluid in patients with bacterial meningitis.
    Modai J; Wolff M; Lebas J; Meulemans A; Manuel C
    Antimicrob Agents Chemother; 1982 Apr; 21(4):551-3. PubMed ID: 6211136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cerebrospinal fluid concentration of lamoxactam with reference to the therapy of gram-negative CNS infections].
    Nix WA; Hey O; Fabricius K
    Nervenarzt; 1982 Dec; 53(12):693-700. PubMed ID: 6218415
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacologic basis for moxalactam therapy for gram-negative enteric bacillary meningitis of infancy.
    McCracken GH; Schaad UB
    Rev Infect Dis; 1982; 4 Suppl():S603-5. PubMed ID: 6218571
    [No Abstract]   [Full Text] [Related]  

  • 6. Diffusion of moxalactam into the cerebrospinal fluid in children with bacterial meningitis.
    Thirumoorthi MC; Buckley JA; Aravind MK; Kauffman RE; Dajani AS
    J Pediatr; 1981 Dec; 99(6):975-9. PubMed ID: 6458673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of gram-negative bacillary meningitis with moxalactam.
    Barriere SL; Wilson CB; Pons VG
    Neurosurgery; 1982 Jun; 10(6 Pt 1):762-5. PubMed ID: 6213879
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of cefoperazone, moxalactam, cefotaxime, trimethoprim and sulphamethoxazole in experimental meningitis.
    Perfect JR; Durack DT
    J Antimicrob Chemother; 1981 Jul; 8(1):49-58. PubMed ID: 6265429
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations.
    Kaplan SL; Mason EO; Kvernland SJ; Calaway EL; Feigin RD
    Rev Infect Dis; 1982; 4 Suppl():S597-602. PubMed ID: 6218570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of moxalactam in the treatment of meningitis: efficacy and meningeal diffusion].
    Fosse T; Raoult D; David MF; Garnier JM; Arnolds M; Gallais H; Giraud F
    Pathol Biol (Paris); 1983 Jun; 31(6):477-9. PubMed ID: 6224124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of moxalactam for bacterial meningitis.
    Kaplan SL; Mason EO; Feigin RD
    J Pediatr; 1982 May; 100(5):843. PubMed ID: 6461736
    [No Abstract]   [Full Text] [Related]  

  • 12. Moxalactam therapy for gram-negative bacillary meningitis.
    Rahal JJ
    Rev Infect Dis; 1982; 4 Suppl():S606-9. PubMed ID: 6218572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxalactam in treatment of recurrent Escherichia coli meningitis and ventriculitis in an infant with agammaglobulinemia.
    Kumar A; Aziz MT
    Drug Intell Clin Pharm; 1981 Jan; 15(1):50-1. PubMed ID: 6456138
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies of moxalactam for gram-negative and Haemophilus influenzae meningitis: an appraisal.
    Dillon HC
    J Pediatr; 1981 Dec; 99(6):907-8. PubMed ID: 6458672
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of 18 cases of purulent meningitis with moxalactam. Pharmacokinetic data].
    Modai J; Vittecoq D; Decazes JM; Wolff M; Meulemans A
    Presse Med; 1983 Jan; 12(3):139-42. PubMed ID: 6220351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of 6059-S in children, particularly in the treatment of bacterial meningitis (author's transl)].
    Kobayashi Y; Haruta T; Kuroki S; Okura K; Fujiwara T; Morikawa Y
    Jpn J Antibiot; 1981 Apr; 34(4):587-98. PubMed ID: 6457167
    [No Abstract]   [Full Text] [Related]  

  • 17. Moxalactam therapy of bacterial meningitis in adults.
    Uwaydah M; Tannir N; Kantarjian H; Osseiran M; Bal'a F
    Antimicrob Agents Chemother; 1983 Feb; 23(2):289-92. PubMed ID: 6220673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Levels of moxalactam in the cerebral ventricles during the treatment of Klebsiella septicemia].
    Veyssier P; Dusehu E; Philippe JM; Lallement PY
    LARC Med; 1983 Jan; 3(1):9-11. PubMed ID: 6221165
    [No Abstract]   [Full Text] [Related]  

  • 19. Penetration of cefotaxime and moxalactam into cerebrospinal fluid of rabbits with experimentally induced Escherichia coli meningitis.
    Nolan CM; Ulmer C
    Rev Infect Dis; 1982; 4 Suppl():S396-400. PubMed ID: 6294789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of gram-negative bacillary meningitis with moxalactam.
    Olson DA; Hoeprich PD; Nolan SM; Goldstein E
    Ann Intern Med; 1981 Sep; 95(3):302-5. PubMed ID: 6455950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.